Market Cap (In INR)
360.24 Billion
Revenue (In INR)
42.08 Billion
Net Income (In INR)
8.16 Billion
Avg. Volume
9874.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1852.55-3485.75
- PE
- -
- EPS
- -
- Beta Value
- 0.104
- ISIN
- INE031B01049
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Yogesh Mannalal Agrawal M.B.A
- Employee Count
- -
- Website
- https://www.ajantapharma.com
- Ipo Date
- Details
- Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as antimalarial, cardiology, ophthalmology, dermatology, pain management, gastroenterology, antihistamine, respiratory, diabetes areas. It also provides tablets, capsules, powder, liquid, jelly, ointments, sterile eye drops, active pharma ingredient. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
More Stocks
-
7472TOBA, INC.
7472
-
NSIT
-
EFG
-
AVA
-
GMLA
-
8028
-
NHIQNantHealth, Inc.
NHIQ
-
KTWIF